#FORMAT=WebAnno TSV 3.2
#T_SP=webanno.custom.Referent|entity|infstat
#T_RL=webanno.custom.Coref|type|BT_webanno.custom.Referent


#Text=1. Introduction
1-1	0-2	1.	_	_	_	_
1-2	3-15	Introduction	abstract	new	_	_

#Text=Acrylamide , a thermal processing contaminant with a low molecular weight , which is soluble in water , is formed when carbohydrate-rich foods are subjected to temperatures above 120 ° C in low-moisture conditions , such as frying , roasting or baking .
2-1	16-26	Acrylamide	substance	new	appos	2-3[4_0]
2-2	27-28	,	_	_	_	_
2-3	29-30	a	substance[4]	giv[4]	coref	3-12[0_4]
2-4	31-38	thermal	abstract[3]|substance[4]	new[3]|giv[4]	coref	9-22[0_3]
2-5	39-49	processing	abstract[3]|substance[4]	new[3]|giv[4]	_	_
2-6	50-61	contaminant	substance[4]	giv[4]	_	_
2-7	62-66	with	substance[4]	giv[4]	_	_
2-8	67-68	a	substance[4]|abstract[5]	giv[4]|new[5]	_	_
2-9	69-72	low	substance[4]|abstract[5]	giv[4]|new[5]	_	_
2-10	73-82	molecular	substance[4]|abstract[5]	giv[4]|new[5]	_	_
2-11	83-89	weight	substance[4]|abstract[5]	giv[4]|new[5]	_	_
2-12	90-91	,	_	_	_	_
2-13	92-97	which	_	_	_	_
2-14	98-100	is	_	_	_	_
2-15	101-108	soluble	_	_	_	_
2-16	109-111	in	_	_	_	_
2-17	112-117	water	substance	new	_	_
2-18	118-119	,	_	_	_	_
2-19	120-122	is	_	_	_	_
2-20	123-129	formed	_	_	_	_
2-21	130-134	when	_	_	_	_
2-22	135-152	carbohydrate-rich	substance[7]	new[7]	coref	3-31[27_7]
2-23	153-158	foods	substance[7]	new[7]	_	_
2-24	159-162	are	_	_	_	_
2-25	163-172	subjected	_	_	_	_
2-26	173-175	to	_	_	_	_
2-27	176-188	temperatures	abstract[8]	new[8]	_	_
2-28	189-194	above	abstract[8]	new[8]	_	_
2-29	195-198	120	abstract[8]|abstract[9]	new[8]|new[9]	_	_
2-30	199-200	°	abstract[8]|abstract[9]	new[8]|new[9]	_	_
2-31	201-202	C	abstract[8]|abstract[9]	new[8]|new[9]	_	_
2-32	203-205	in	abstract[8]	new[8]	_	_
2-33	206-218	low-moisture	abstract[8]|abstract[10]	new[8]|new[10]	coref	17-35[197_10]
2-34	219-229	conditions	abstract[8]|abstract[10]	new[8]|new[10]	_	_
2-35	230-231	,	abstract[8]|abstract[10]	new[8]|new[10]	_	_
2-36	232-236	such	abstract[8]|abstract[10]	new[8]|new[10]	_	_
2-37	237-239	as	abstract[8]|abstract[10]	new[8]|new[10]	_	_
2-38	240-246	frying	abstract[8]|abstract[10]|abstract	new[8]|new[10]|new	coref	9-53
2-39	247-248	,	abstract[8]|abstract[10]	new[8]|new[10]	_	_
2-40	249-257	roasting	abstract[8]|abstract[10]|abstract	new[8]|new[10]|new	_	_
2-41	258-260	or	abstract[8]|abstract[10]	new[8]|new[10]	_	_
2-42	261-267	baking	abstract[8]|abstract[10]|person	new[8]|new[10]|new	_	_
2-43	268-269	.	_	_	_	_

#Text=Several studies consider Maillard reactions to be the main pathway for acrylamide , 5 hydroxymethylfurfural , methylglyoxal – lysine dimers , Nε – carboxymethyl – lysine and pyrraline formation in processed foods , particularly reactions between the carbonyl group of reducing sugars and amino acids .
3-1	270-277	Several	abstract[14]	new[14]	coref	12-17[142_14]
3-2	278-285	studies	abstract[14]	new[14]	_	_
3-3	286-294	consider	_	_	_	_
3-4	295-303	Maillard	person|event[16]	new|new[16]	appos	3-34[28_16]
3-5	304-313	reactions	event[16]	new[16]	_	_
3-6	314-316	to	_	_	_	_
3-7	317-319	be	_	_	_	_
3-8	320-323	the	abstract[17]	new[17]	_	_
3-9	324-328	main	abstract[17]	new[17]	_	_
3-10	329-336	pathway	abstract[17]	new[17]	_	_
3-11	337-340	for	abstract[17]	new[17]	_	_
3-12	341-351	acrylamide	abstract[17]|substance	new[17]|giv	coref	4-8[36_0]
3-13	352-353	,	abstract[17]	new[17]	_	_
3-14	354-355	5	abstract[17]|abstract[19]	new[17]|new[19]	_	_
3-15	356-377	hydroxymethylfurfural	abstract[17]|abstract[19]	new[17]|new[19]	_	_
3-16	378-379	,	abstract[17]	new[17]	_	_
3-17	380-393	methylglyoxal	abstract[17]|abstract	new[17]|new	_	_
3-18	394-395	–	abstract[17]	new[17]	_	_
3-19	396-402	lysine	abstract[17]|substance	new[17]|new	coref	3-26
3-20	403-409	dimers	abstract[17]	new[17]	_	_
3-21	410-411	,	abstract[17]	new[17]	_	_
3-22	412-414	Nε	abstract[17]|substance|event[26]	new[17]|new|new[26]	coref	9-18[96_26]
3-23	415-416	–	abstract[17]|event[26]	new[17]|new[26]	_	_
3-24	417-430	carboxymethyl	abstract[17]|place|event[26]	new[17]|new|new[26]	_	_
3-25	431-432	–	abstract[17]|event[26]	new[17]|new[26]	_	_
3-26	433-439	lysine	abstract[17]|substance|event[26]	new[17]|giv|new[26]	_	_
3-27	440-443	and	abstract[17]|event[26]	new[17]|new[26]	_	_
3-28	444-453	pyrraline	abstract[17]|abstract|event[26]	new[17]|new|new[26]	_	_
3-29	454-463	formation	abstract[17]|event[26]	new[17]|new[26]	_	_
3-30	464-466	in	abstract[17]|event[26]	new[17]|new[26]	_	_
3-31	467-476	processed	abstract[17]|event[26]|substance[27]	new[17]|new[26]|giv[27]	_	_
3-32	477-482	foods	abstract[17]|event[26]|substance[27]	new[17]|new[26]|giv[27]	_	_
3-33	483-484	,	_	_	_	_
3-34	485-497	particularly	event[28]	giv[28]	_	_
3-35	498-507	reactions	event[28]	giv[28]	_	_
3-36	508-515	between	event[28]	giv[28]	_	_
3-37	516-519	the	event[28]|substance[30]	giv[28]|new[30]	_	_
3-38	520-528	carbonyl	event[28]|object|substance[30]	giv[28]|new|new[30]	_	_
3-39	529-534	group	event[28]|substance[30]	giv[28]|new[30]	_	_
3-40	535-537	of	event[28]|substance[30]	giv[28]|new[30]	_	_
3-41	538-546	reducing	event[28]|substance[30]|substance[31]	giv[28]|new[30]|new[31]	_	_
3-42	547-553	sugars	event[28]|substance[30]|substance[31]	giv[28]|new[30]|new[31]	_	_
3-43	554-557	and	event[28]|substance[30]	giv[28]|new[30]	_	_
3-44	558-563	amino	event[28]|substance[30]|object|substance[33]	giv[28]|new[30]|new|new[33]	_	_
3-45	564-569	acids	event[28]|substance[30]|substance[33]	giv[28]|new[30]|new[33]	_	_
3-46	570-571	.	_	_	_	_

#Text=Initial reports showed relatively high concentrations of acrylamide in high-carbohydrate foodstuffs , such as crispy bread , breakfast cereals , pastries , coffee , French fries and crisps .
4-1	572-579	Initial	abstract[34]	new[34]	_	_
4-2	580-587	reports	abstract[34]	new[34]	_	_
4-3	588-594	showed	_	_	_	_
4-4	595-605	relatively	substance[35]	new[35]	_	_
4-5	606-610	high	substance[35]	new[35]	_	_
4-6	611-625	concentrations	substance[35]	new[35]	_	_
4-7	626-628	of	substance[35]	new[35]	_	_
4-8	629-639	acrylamide	substance[35]|substance[36]	new[35]|giv[36]	coref	5-8[0_36]
4-9	640-642	in	substance[35]|substance[36]	new[35]|giv[36]	_	_
4-10	643-660	high-carbohydrate	substance[35]|substance[36]|substance[37]	new[35]|giv[36]|new[37]	_	_
4-11	661-671	foodstuffs	substance[35]|substance[36]|substance[37]	new[35]|giv[36]|new[37]	_	_
4-12	672-673	,	substance[35]	new[35]	_	_
4-13	674-678	such	substance[35]	new[35]	_	_
4-14	679-681	as	substance[35]	new[35]	_	_
4-15	682-688	crispy	substance[35]|object[38]	new[35]|new[38]	_	_
4-16	689-694	bread	substance[35]|object[38]	new[35]|new[38]	_	_
4-17	695-696	,	substance[35]	new[35]	_	_
4-18	697-706	breakfast	substance[35]|event|substance[40]	new[35]|new|new[40]	_	_
4-19	707-714	cereals	substance[35]|substance[40]	new[35]|new[40]	_	_
4-20	715-716	,	substance[35]	new[35]	_	_
4-21	717-725	pastries	substance[35]|object	new[35]|new	_	_
4-22	726-727	,	substance[35]	new[35]	_	_
4-23	728-734	coffee	substance[35]|substance	new[35]|new	_	_
4-24	735-736	,	substance[35]	new[35]	_	_
4-25	737-743	French	substance[35]|object[43]	new[35]|new[43]	_	_
4-26	744-749	fries	substance[35]|object[43]	new[35]|new[43]	_	_
4-27	750-753	and	substance[35]	new[35]	_	_
4-28	754-760	crisps	substance[35]|object	new[35]|new	coref	7-28
4-29	761-762	.	_	_	_	_

#Text=In general , potato products present higher acrylamide contents ( 250 – 4000 µg kg−1 ) compared to other food products , because of the higher concentration of asparagine in potato tubers .
5-1	763-765	In	_	_	_	_
5-2	766-773	general	_	_	_	_
5-3	774-775	,	_	_	_	_
5-4	776-782	potato	object|substance[46]	new|new[46]	coref|coref	5-19[50_46]|5-31
5-5	783-791	products	substance[46]	new[46]	_	_
5-6	792-799	present	_	_	_	_
5-7	800-806	higher	abstract[48]	new[48]	appos	5-11[49_48]
5-8	807-817	acrylamide	substance|abstract[48]	giv|new[48]	coref	6-1
5-9	818-826	contents	abstract[48]	new[48]	_	_
5-10	827-828	(	_	_	_	_
5-11	829-832	250	abstract[49]	giv[49]	_	_
5-12	833-834	–	abstract[49]	giv[49]	_	_
5-13	835-839	4000	abstract[49]	giv[49]	_	_
5-14	840-842	µg	abstract[49]	giv[49]	_	_
5-15	843-847	kg−1	abstract[49]	giv[49]	_	_
5-16	848-849	)	_	_	_	_
5-17	850-858	compared	_	_	_	_
5-18	859-861	to	_	_	_	_
5-19	862-867	other	substance[50]	giv[50]	_	_
5-20	868-872	food	substance[50]	giv[50]	_	_
5-21	873-881	products	substance[50]	giv[50]	_	_
5-22	882-883	,	_	_	_	_
5-23	884-891	because	_	_	_	_
5-24	892-894	of	_	_	_	_
5-25	895-898	the	substance[51]	new[51]	_	_
5-26	899-905	higher	substance[51]	new[51]	_	_
5-27	906-919	concentration	substance[51]	new[51]	_	_
5-28	920-922	of	substance[51]	new[51]	_	_
5-29	923-933	asparagine	substance[51]|substance	new[51]|new	_	_
5-30	934-936	in	substance[51]	new[51]	_	_
5-31	937-943	potato	substance[51]|object|plant[54]	new[51]|giv|new[54]	coref	9-61
5-32	944-950	tubers	substance[51]|plant[54]	new[51]|new[54]	_	_
5-33	951-952	.	_	_	_	_

#Text=Acrylamide has been classified by the Agency for Research on Cancer as “ probably carcinogenic to humans ” ( Group 2A ) and , in the latest report from the European Food Safety Authority Expert Panel on Contaminants in the Food Chain ( CONTAM , 2015 ) , the margins of exposure for acrylamide lead to concerns regarding their neoplastic effects , based on animal evidence .
6-1	953-963	Acrylamide	substance	giv	coref	6-54
6-2	964-967	has	_	_	_	_
6-3	968-972	been	_	_	_	_
6-4	973-983	classified	_	_	_	_
6-5	984-986	by	_	_	_	_
6-6	987-990	the	organization[56]	new[56]	_	_
6-7	991-997	Agency	organization[56]	new[56]	_	_
6-8	998-1001	for	organization[56]	new[56]	_	_
6-9	1002-1010	Research	organization[56]|organization[57]	new[56]|new[57]	_	_
6-10	1011-1013	on	organization[56]|organization[57]	new[56]|new[57]	_	_
6-11	1014-1020	Cancer	organization[56]|organization[57]|abstract	new[56]|new[57]|new	_	_
6-12	1021-1023	as	_	_	_	_
6-13	1024-1025	“	_	_	_	_
6-14	1026-1034	probably	_	_	_	_
6-15	1035-1047	carcinogenic	_	_	_	_
6-16	1048-1050	to	_	_	_	_
6-17	1051-1057	humans	animal	new	coref	13-4
6-18	1058-1059	”	_	_	_	_
6-19	1060-1061	(	_	_	_	_
6-20	1062-1067	Group	_	_	_	_
6-21	1068-1070	2A	_	_	_	_
6-22	1071-1072	)	_	_	_	_
6-23	1073-1076	and	_	_	_	_
6-24	1077-1078	,	_	_	_	_
6-25	1079-1081	in	_	_	_	_
6-26	1082-1085	the	abstract[60]	new[60]	_	_
6-27	1086-1092	latest	abstract[60]	new[60]	_	_
6-28	1093-1099	report	abstract[60]	new[60]	_	_
6-29	1100-1104	from	abstract[60]	new[60]	_	_
6-30	1105-1108	the	abstract[60]|abstract[65]	new[60]|new[65]	_	_
6-31	1109-1117	European	abstract[60]|organization[63]|abstract[65]	new[60]|new[63]|new[65]	_	_
6-32	1118-1122	Food	abstract[60]|substance|organization[63]|abstract[65]	new[60]|new|new[63]|new[65]	coref	6-41
6-33	1123-1129	Safety	abstract[60]|abstract|organization[63]|abstract[65]	new[60]|new|new[63]|new[65]	_	_
6-34	1130-1139	Authority	abstract[60]|organization[63]|abstract[65]	new[60]|new[63]|new[65]	_	_
6-35	1140-1146	Expert	abstract[60]|person|abstract[65]	new[60]|new|new[65]	_	_
6-36	1147-1152	Panel	abstract[60]|abstract[65]	new[60]|new[65]	_	_
6-37	1153-1155	on	abstract[60]|abstract[65]	new[60]|new[65]	_	_
6-38	1156-1168	Contaminants	abstract[60]|abstract[65]|abstract[66]	new[60]|new[65]|new[66]	_	_
6-39	1169-1171	in	abstract[60]|abstract[65]|abstract[66]	new[60]|new[65]|new[66]	_	_
6-40	1172-1175	the	abstract[60]|abstract[65]|abstract[66]|abstract[68]	new[60]|new[65]|new[66]|new[68]	_	_
6-41	1176-1180	Food	abstract[60]|abstract[65]|abstract[66]|substance|abstract[68]	new[60]|new[65]|new[66]|giv|new[68]	coref	7-18
6-42	1181-1186	Chain	abstract[60]|abstract[65]|abstract[66]|abstract[68]	new[60]|new[65]|new[66]|new[68]	_	_
6-43	1187-1188	(	_	_	_	_
6-44	1189-1195	CONTAM	_	_	_	_
6-45	1196-1197	,	_	_	_	_
6-46	1198-1202	2015	time	new	_	_
6-47	1203-1204	)	_	_	_	_
6-48	1205-1206	,	_	_	_	_
6-49	1207-1210	the	abstract[70]	new[70]	_	_
6-50	1211-1218	margins	abstract[70]	new[70]	_	_
6-51	1219-1221	of	abstract[70]	new[70]	_	_
6-52	1222-1230	exposure	abstract[70]|abstract[71]	new[70]|new[71]	_	_
6-53	1231-1234	for	abstract[70]|abstract[71]	new[70]|new[71]	_	_
6-54	1235-1245	acrylamide	abstract[70]|abstract[71]|substance	new[70]|new[71]|giv	coref	7-16
6-55	1246-1250	lead	_	_	_	_
6-56	1251-1253	to	_	_	_	_
6-57	1254-1262	concerns	abstract[73]	new[73]	ana	6-59[0_73]
6-58	1263-1272	regarding	abstract[73]	new[73]	_	_
6-59	1273-1278	their	abstract[73]|abstract|abstract[75]	new[73]|giv|new[75]	_	_
6-60	1279-1289	neoplastic	abstract[73]|abstract[75]	new[73]|new[75]	_	_
6-61	1290-1297	effects	abstract[73]|abstract[75]	new[73]|new[75]	_	_
6-62	1298-1299	,	_	_	_	_
6-63	1300-1305	based	_	_	_	_
6-64	1306-1308	on	_	_	_	_
6-65	1309-1315	animal	animal|abstract[77]	new|new[77]	_	_
6-66	1316-1324	evidence	abstract[77]	new[77]	_	_
6-67	1325-1326	.	_	_	_	_

#Text=Therefore , the European Commission recently established “ indicative ” levels for the presence of acrylamide in food , suggesting a limit of 750 µg kg−1 for crisps .
7-1	1327-1336	Therefore	_	_	_	_
7-2	1337-1338	,	_	_	_	_
7-3	1339-1342	the	organization[78]	new[78]	_	_
7-4	1343-1351	European	organization[78]	new[78]	_	_
7-5	1352-1362	Commission	organization[78]	new[78]	_	_
7-6	1363-1371	recently	_	_	_	_
7-7	1372-1383	established	_	_	_	_
7-8	1384-1385	“	abstract[79]	new[79]	coref	10-16[121_79]
7-9	1386-1396	indicative	abstract[79]	new[79]	_	_
7-10	1397-1398	”	abstract[79]	new[79]	_	_
7-11	1399-1405	levels	abstract[79]	new[79]	_	_
7-12	1406-1409	for	abstract[79]	new[79]	_	_
7-13	1410-1413	the	abstract[79]|abstract[80]	new[79]|new[80]	_	_
7-14	1414-1422	presence	abstract[79]|abstract[80]	new[79]|new[80]	_	_
7-15	1423-1425	of	abstract[79]|abstract[80]	new[79]|new[80]	_	_
7-16	1426-1436	acrylamide	abstract[79]|abstract[80]|substance	new[79]|new[80]|giv	coref	8-17[91_0]
7-17	1437-1439	in	abstract[79]|abstract[80]	new[79]|new[80]	_	_
7-18	1440-1444	food	abstract[79]|abstract[80]|substance	new[79]|new[80]|giv	coref	8-10
7-19	1445-1446	,	_	_	_	_
7-20	1447-1457	suggesting	_	_	_	_
7-21	1458-1459	a	abstract[83]	new[83]	_	_
7-22	1460-1465	limit	abstract[83]	new[83]	_	_
7-23	1466-1468	of	abstract[83]	new[83]	_	_
7-24	1469-1472	750	abstract[83]|abstract[84]	new[83]|new[84]	_	_
7-25	1473-1475	µg	abstract[83]|abstract[84]	new[83]|new[84]	_	_
7-26	1476-1480	kg−1	abstract[83]|abstract[84]	new[83]|new[84]	_	_
7-27	1481-1484	for	abstract[83]	new[83]	_	_
7-28	1485-1491	crisps	abstract[83]|object	new[83]|giv	coref	12-28
7-29	1492-1493	.	_	_	_	_

#Text=Previously , the European Union and FDA had encouraged food industries to reduce the presence of this contaminant .
8-1	1494-1504	Previously	_	_	_	_
8-2	1505-1506	,	_	_	_	_
8-3	1507-1510	the	organization[86]	new[86]	_	_
8-4	1511-1519	European	organization[86]	new[86]	_	_
8-5	1520-1525	Union	organization[86]	new[86]	_	_
8-6	1526-1529	and	_	_	_	_
8-7	1530-1533	FDA	organization	new	_	_
8-8	1534-1537	had	_	_	_	_
8-9	1538-1548	encouraged	_	_	_	_
8-10	1549-1553	food	substance|organization[89]	giv|new[89]	coref|coref	9-7|10-7[117_89]
8-11	1554-1564	industries	organization[89]	new[89]	_	_
8-12	1565-1567	to	_	_	_	_
8-13	1568-1574	reduce	_	_	_	_
8-14	1575-1578	the	abstract[90]	new[90]	_	_
8-15	1579-1587	presence	abstract[90]	new[90]	_	_
8-16	1588-1590	of	abstract[90]	new[90]	_	_
8-17	1591-1595	this	abstract[90]|substance[91]	new[90]|giv[91]	coref	9-18[0_91]
8-18	1596-1607	contaminant	abstract[90]|substance[91]	new[90]|giv[91]	_	_
8-19	1608-1609	.	_	_	_	_

#Text=In response to this , the food industry has been forced to apply different strategies to reduce acrylamide formation , applying processing modifications according to recommendations published by the European Food and Drink Federation in the document “ Acrylamide Toolbox ” , which includes the following variables : temperature and time during frying , blanching treatment , and thickness of potato slices .
9-1	1610-1612	In	_	_	_	_
9-2	1613-1621	response	_	_	_	_
9-3	1622-1624	to	_	_	_	_
9-4	1625-1629	this	_	_	_	_
9-5	1630-1631	,	_	_	_	_
9-6	1632-1635	the	organization[93]	new[93]	_	_
9-7	1636-1640	food	substance|organization[93]	giv|new[93]	coref	9-31
9-8	1641-1649	industry	organization[93]	new[93]	_	_
9-9	1650-1653	has	_	_	_	_
9-10	1654-1658	been	_	_	_	_
9-11	1659-1665	forced	_	_	_	_
9-12	1666-1668	to	_	_	_	_
9-13	1669-1674	apply	_	_	_	_
9-14	1675-1684	different	abstract[94]	new[94]	coref	18-5[201_94]
9-15	1685-1695	strategies	abstract[94]	new[94]	_	_
9-16	1696-1698	to	_	_	_	_
9-17	1699-1705	reduce	_	_	_	_
9-18	1706-1716	acrylamide	substance|event[96]	giv|giv[96]	coref	9-39
9-19	1717-1726	formation	event[96]	giv[96]	_	_
9-20	1727-1728	,	_	_	_	_
9-21	1729-1737	applying	_	_	_	_
9-22	1738-1748	processing	abstract|abstract[98]	giv|new[98]	_	_
9-23	1749-1762	modifications	abstract[98]	new[98]	_	_
9-24	1763-1772	according	_	_	_	_
9-25	1773-1775	to	_	_	_	_
9-26	1776-1791	recommendations	abstract[99]	new[99]	_	_
9-27	1792-1801	published	abstract[99]	new[99]	_	_
9-28	1802-1804	by	abstract[99]	new[99]	_	_
9-29	1805-1808	the	abstract[99]|organization[102]	new[99]|new[102]	_	_
9-30	1809-1817	European	abstract[99]|organization[102]	new[99]|new[102]	_	_
9-31	1818-1822	Food	abstract[99]|substance|organization[102]	new[99]|giv|new[102]	coref	10-8
9-32	1823-1826	and	abstract[99]|organization[102]	new[99]|new[102]	_	_
9-33	1827-1832	Drink	abstract[99]|person|organization[102]	new[99]|new|new[102]	_	_
9-34	1833-1843	Federation	abstract[99]|organization[102]	new[99]|new[102]	_	_
9-35	1844-1846	in	abstract[99]	new[99]	_	_
9-36	1847-1850	the	abstract[99]|abstract[103]	new[99]|new[103]	_	_
9-37	1851-1859	document	abstract[99]|abstract[103]	new[99]|new[103]	_	_
9-38	1860-1861	“	abstract[99]	new[99]	_	_
9-39	1862-1872	Acrylamide	abstract[99]|substance|substance[105]	new[99]|giv|new[105]	coref	10-17
9-40	1873-1880	Toolbox	abstract[99]|substance[105]	new[99]|new[105]	_	_
9-41	1881-1882	”	abstract[99]	new[99]	_	_
9-42	1883-1884	,	abstract[99]	new[99]	_	_
9-43	1885-1890	which	abstract[99]	new[99]	_	_
9-44	1891-1899	includes	abstract[99]	new[99]	_	_
9-45	1900-1903	the	abstract[99]|abstract[106]	new[99]|new[106]	appos	9-49[0_106]
9-46	1904-1913	following	abstract[99]|abstract[106]	new[99]|new[106]	_	_
9-47	1914-1923	variables	abstract[99]|abstract[106]	new[99]|new[106]	_	_
9-48	1924-1925	:	_	_	_	_
9-49	1926-1937	temperature	abstract|abstract[108]	giv|giv[108]	appos|appos	9-49[108_0]|9-51[109_108]
9-50	1938-1941	and	abstract[108]	giv[108]	_	_
9-51	1942-1946	time	abstract[108]|abstract[109]	giv[108]|giv[109]	appos	9-59[112_109]
9-52	1947-1953	during	abstract[108]|abstract[109]	giv[108]|giv[109]	_	_
9-53	1954-1960	frying	abstract[108]|abstract[109]|abstract	giv[108]|giv[109]|giv	coref	11-13
9-54	1961-1962	,	abstract[108]|abstract[109]	giv[108]|giv[109]	_	_
9-55	1963-1972	blanching	abstract[108]|abstract[109]|event[111]	giv[108]|giv[109]|new[111]	_	_
9-56	1973-1982	treatment	abstract[108]|abstract[109]|event[111]	giv[108]|giv[109]|new[111]	_	_
9-57	1983-1984	,	abstract[108]	giv[108]	_	_
9-58	1985-1988	and	abstract[108]	giv[108]	_	_
9-59	1989-1998	thickness	abstract[108]|abstract[112]	giv[108]|giv[112]	_	_
9-60	1999-2001	of	abstract[108]|abstract[112]	giv[108]|giv[112]	_	_
9-61	2002-2008	potato	abstract[108]|abstract[112]|object|object[114]	giv[108]|giv[112]|giv|new[114]	coref	10-13
9-62	2009-2015	slices	abstract[108]|abstract[112]|object[114]	giv[108]|giv[112]|new[114]	_	_
9-63	2016-2017	.	_	_	_	_

#Text=However , the main challenge for the food industries is in producing potato chips with low acrylamide levels without affecting their sensory properties .
10-1	2018-2025	However	_	_	_	_
10-2	2026-2027	,	_	_	_	_
10-3	2028-2031	the	event[115]	new[115]	ana	11-2[0_115]
10-4	2032-2036	main	event[115]	new[115]	_	_
10-5	2037-2046	challenge	event[115]	new[115]	_	_
10-6	2047-2050	for	event[115]	new[115]	_	_
10-7	2051-2054	the	event[115]|organization[117]	new[115]|giv[117]	_	_
10-8	2055-2059	food	event[115]|substance|organization[117]	new[115]|giv|giv[117]	coref	12-10
10-9	2060-2070	industries	event[115]|organization[117]	new[115]|giv[117]	_	_
10-10	2071-2073	is	_	_	_	_
10-11	2074-2076	in	_	_	_	_
10-12	2077-2086	producing	_	_	_	_
10-13	2087-2093	potato	object|object[119]	giv|new[119]	coref|coref	12-1|12-1[137_119]
10-14	2094-2099	chips	object[119]	new[119]	_	_
10-15	2100-2104	with	object[119]	new[119]	_	_
10-16	2105-2108	low	object[119]|abstract[121]	new[119]|giv[121]	ana	10-21[0_121]
10-17	2109-2119	acrylamide	object[119]|substance|abstract[121]	new[119]|giv|giv[121]	coref	11-16
10-18	2120-2126	levels	object[119]|abstract[121]	new[119]|giv[121]	_	_
10-19	2127-2134	without	_	_	_	_
10-20	2135-2144	affecting	_	_	_	_
10-21	2145-2150	their	abstract|abstract[123]	giv|new[123]	coref	18-21[208_123]
10-22	2151-2158	sensory	abstract[123]	new[123]	_	_
10-23	2159-2169	properties	abstract[123]	new[123]	_	_
10-24	2170-2171	.	_	_	_	_

#Text=Although it is important to evaluate the effect of pre-treatments on the frying process on acrylamide mitigation , it is also necessary to determine their influence on its bioavailability .
11-1	2172-2180	Although	_	_	_	_
11-2	2181-2183	it	event	giv	ana	11-19
11-3	2184-2186	is	_	_	_	_
11-4	2187-2196	important	_	_	_	_
11-5	2197-2199	to	_	_	_	_
11-6	2200-2208	evaluate	_	_	_	_
11-7	2209-2212	the	abstract[125]	new[125]	_	_
11-8	2213-2219	effect	abstract[125]	new[125]	_	_
11-9	2220-2222	of	abstract[125]	new[125]	_	_
11-10	2223-2237	pre-treatments	abstract[125]|substance[126]	new[125]|new[126]	ana	11-25[0_126]
11-11	2238-2240	on	abstract[125]|substance[126]	new[125]|new[126]	_	_
11-12	2241-2244	the	abstract[125]|substance[126]|event[128]	new[125]|new[126]|new[128]	coref	12-32[147_128]
11-13	2245-2251	frying	abstract[125]|substance[126]|abstract|event[128]	new[125]|new[126]|giv|new[128]	_	_
11-14	2252-2259	process	abstract[125]|substance[126]|event[128]	new[125]|new[126]|new[128]	_	_
11-15	2260-2262	on	_	_	_	_
11-16	2263-2273	acrylamide	substance|abstract[130]	giv|new[130]	coref|coref	12-26|18-6[200_130]
11-17	2274-2284	mitigation	abstract[130]	new[130]	_	_
11-18	2285-2286	,	_	_	_	_
11-19	2287-2289	it	event	giv	ana	11-28
11-20	2290-2292	is	_	_	_	_
11-21	2293-2297	also	_	_	_	_
11-22	2298-2307	necessary	_	_	_	_
11-23	2308-2310	to	_	_	_	_
11-24	2311-2320	determine	_	_	_	_
11-25	2321-2326	their	substance|abstract[133]	giv|new[133]	coref	18-18[207_133]
11-26	2327-2336	influence	abstract[133]	new[133]	_	_
11-27	2337-2339	on	abstract[133]	new[133]	_	_
11-28	2340-2343	its	abstract[133]|event|abstract[135]	new[133]|giv|new[135]	coref	12-23[143_135]
11-29	2344-2359	bioavailability	abstract[133]|abstract[135]	new[133]|new[135]	_	_
11-30	2360-2361	.	_	_	_	_

#Text=Potato chips are an important part of the snack food market in many countries , and few studies have been published about the bioavailability of acrylamide after crisps have been through the digestion process .
12-1	2362-2368	Potato	object|object[137]	giv|giv[137]	_	_
12-2	2369-2374	chips	object[137]	giv[137]	_	_
12-3	2375-2378	are	_	_	_	_
12-4	2379-2381	an	_	_	_	_
12-5	2382-2391	important	_	_	_	_
12-6	2392-2396	part	_	_	_	_
12-7	2397-2399	of	_	_	_	_
12-8	2400-2403	the	abstract[140]	new[140]	ana	14-9[0_140]
12-9	2404-2409	snack	object|abstract[140]	new|new[140]	_	_
12-10	2410-2414	food	substance|abstract[140]	giv|new[140]	coref	13-8
12-11	2415-2421	market	abstract[140]	new[140]	_	_
12-12	2422-2424	in	_	_	_	_
12-13	2425-2429	many	place[141]	new[141]	_	_
12-14	2430-2439	countries	place[141]	new[141]	_	_
12-15	2440-2441	,	_	_	_	_
12-16	2442-2445	and	_	_	_	_
12-17	2446-2449	few	abstract[142]	giv[142]	_	_
12-18	2450-2457	studies	abstract[142]	giv[142]	_	_
12-19	2458-2462	have	_	_	_	_
12-20	2463-2467	been	_	_	_	_
12-21	2468-2477	published	_	_	_	_
12-22	2478-2483	about	_	_	_	_
12-23	2484-2487	the	abstract[143]	giv[143]	_	_
12-24	2488-2503	bioavailability	abstract[143]	giv[143]	_	_
12-25	2504-2506	of	abstract[143]	giv[143]	_	_
12-26	2507-2517	acrylamide	abstract[143]|substance	giv[143]|giv	coref	13-1
12-27	2518-2523	after	_	_	_	_
12-28	2524-2530	crisps	object	giv	_	_
12-29	2531-2535	have	_	_	_	_
12-30	2536-2540	been	_	_	_	_
12-31	2541-2548	through	_	_	_	_
12-32	2549-2552	the	event[147]	giv[147]	coref	14-30[167_147]
12-33	2553-2562	digestion	abstract|event[147]	new|giv[147]	coref	14-31
12-34	2563-2570	process	event[147]	giv[147]	_	_
12-35	2571-2572	.	_	_	_	_

#Text=Acrylamide intake in humans occurs mainly via food ingestion , where the total amount of this compound does not necessarily reflect the available amount to the body .
13-1	2573-2583	Acrylamide	substance|event[149]	giv|new[149]	coref	18-6
13-2	2584-2590	intake	event[149]	new[149]	_	_
13-3	2591-2593	in	event[149]	new[149]	_	_
13-4	2594-2600	humans	event[149]|animal	new[149]|giv	_	_
13-5	2601-2607	occurs	_	_	_	_
13-6	2608-2614	mainly	_	_	_	_
13-7	2615-2618	via	_	_	_	_
13-8	2619-2623	food	substance|event[152]	giv|new[152]	coref	14-6[158_0]
13-9	2624-2633	ingestion	event[152]	new[152]	_	_
13-10	2634-2635	,	event[152]	new[152]	_	_
13-11	2636-2641	where	event[152]	new[152]	_	_
13-12	2642-2645	the	event[152]|substance[153]	new[152]|new[153]	_	_
13-13	2646-2651	total	event[152]|substance[153]	new[152]|new[153]	_	_
13-14	2652-2658	amount	event[152]|substance[153]	new[152]|new[153]	_	_
13-15	2659-2661	of	event[152]|substance[153]	new[152]|new[153]	_	_
13-16	2662-2666	this	event[152]|substance[153]|substance[154]	new[152]|new[153]|new[154]	coref	15-13[171_154]
13-17	2667-2675	compound	event[152]|substance[153]|substance[154]	new[152]|new[153]|new[154]	_	_
13-18	2676-2680	does	event[152]	new[152]	_	_
13-19	2681-2684	not	event[152]	new[152]	_	_
13-20	2685-2696	necessarily	event[152]	new[152]	_	_
13-21	2697-2704	reflect	event[152]	new[152]	_	_
13-22	2705-2708	the	event[152]|substance[155]	new[152]|new[155]	coref	15-10[170_155]
13-23	2709-2718	available	event[152]|substance[155]	new[152]|new[155]	_	_
13-24	2719-2725	amount	event[152]|substance[155]	new[152]|new[155]	_	_
13-25	2726-2728	to	event[152]|substance[155]	new[152]|new[155]	_	_
13-26	2729-2732	the	event[152]|substance[155]|object[156]	new[152]|new[155]|new[156]	_	_
13-27	2733-2737	body	event[152]|substance[155]|object[156]	new[152]|new[155]|new[156]	_	_
13-28	2738-2739	.	_	_	_	_

#Text=There are chemical changes in the food when it enters the digestive tract , because of pH variations , and the action of several enzymes in every stage of the digestion process .
14-1	2740-2745	There	_	_	_	_
14-2	2746-2749	are	_	_	_	_
14-3	2750-2758	chemical	abstract[157]	new[157]	_	_
14-4	2759-2766	changes	abstract[157]	new[157]	_	_
14-5	2767-2769	in	abstract[157]	new[157]	_	_
14-6	2770-2773	the	abstract[157]|substance[158]	new[157]|giv[158]	coref	15-25[0_158]
14-7	2774-2778	food	abstract[157]|substance[158]	new[157]|giv[158]	_	_
14-8	2779-2783	when	abstract[157]	new[157]	_	_
14-9	2784-2786	it	abstract[157]|abstract	new[157]|giv	_	_
14-10	2787-2793	enters	abstract[157]	new[157]	_	_
14-11	2794-2797	the	abstract[157]|object[160]	new[157]|new[160]	coref	15-28[176_160]
14-12	2798-2807	digestive	abstract[157]|object[160]	new[157]|new[160]	_	_
14-13	2808-2813	tract	abstract[157]|object[160]	new[157]|new[160]	_	_
14-14	2814-2815	,	abstract[157]	new[157]	_	_
14-15	2816-2823	because	abstract[157]	new[157]	_	_
14-16	2824-2826	of	abstract[157]	new[157]	_	_
14-17	2827-2829	pH	abstract[157]|abstract|abstract[162]	new[157]|new|new[162]	_	_
14-18	2830-2840	variations	abstract[157]|abstract[162]	new[157]|new[162]	_	_
14-19	2841-2842	,	_	_	_	_
14-20	2843-2846	and	_	_	_	_
14-21	2847-2850	the	event[163]	new[163]	_	_
14-22	2851-2857	action	event[163]	new[163]	_	_
14-23	2858-2860	of	event[163]	new[163]	_	_
14-24	2861-2868	several	event[163]|substance[164]	new[163]|new[164]	_	_
14-25	2869-2876	enzymes	event[163]|substance[164]	new[163]|new[164]	_	_
14-26	2877-2879	in	event[163]|substance[164]	new[163]|new[164]	_	_
14-27	2880-2885	every	event[163]|substance[164]|abstract[165]	new[163]|new[164]|new[165]	_	_
14-28	2886-2891	stage	event[163]|substance[164]|abstract[165]	new[163]|new[164]|new[165]	_	_
14-29	2892-2894	of	event[163]|substance[164]|abstract[165]	new[163]|new[164]|new[165]	_	_
14-30	2895-2898	the	event[163]|substance[164]|abstract[165]|event[167]	new[163]|new[164]|new[165]|giv[167]	_	_
14-31	2899-2908	digestion	event[163]|substance[164]|abstract[165]|abstract|event[167]	new[163]|new[164]|new[165]|giv|giv[167]	coref	18-31
14-32	2909-2916	process	event[163]|substance[164]|abstract[165]|event[167]	new[163]|new[164]|new[165]|giv[167]	_	_
14-33	2917-2918	.	_	_	_	_

#Text=In this sense , bioaccessibility is used to evaluate the amount of a chemical compound available for absorption after it is released from the food matrix into the gastrointestinal tract .
15-1	2919-2921	In	_	_	_	_
15-2	2922-2926	this	abstract[168]	new[168]	_	_
15-3	2927-2932	sense	abstract[168]	new[168]	_	_
15-4	2933-2934	,	_	_	_	_
15-5	2935-2951	bioaccessibility	abstract	new	coref	16-8[178_0]
15-6	2952-2954	is	_	_	_	_
15-7	2955-2959	used	_	_	_	_
15-8	2960-2962	to	_	_	_	_
15-9	2963-2971	evaluate	_	_	_	_
15-10	2972-2975	the	substance[170]	giv[170]	_	_
15-11	2976-2982	amount	substance[170]	giv[170]	_	_
15-12	2983-2985	of	substance[170]	giv[170]	_	_
15-13	2986-2987	a	substance[170]|substance[171]	giv[170]|giv[171]	ana	15-20[0_171]
15-14	2988-2996	chemical	substance[170]|substance[171]	giv[170]|giv[171]	_	_
15-15	2997-3005	compound	substance[170]|substance[171]	giv[170]|giv[171]	_	_
15-16	3006-3015	available	substance[170]|substance[171]	giv[170]|giv[171]	_	_
15-17	3016-3019	for	_	_	_	_
15-18	3020-3030	absorption	event	new	_	_
15-19	3031-3036	after	_	_	_	_
15-20	3037-3039	it	substance	giv	_	_
15-21	3040-3042	is	_	_	_	_
15-22	3043-3051	released	_	_	_	_
15-23	3052-3056	from	_	_	_	_
15-24	3057-3060	the	substance[175]	new[175]	_	_
15-25	3061-3065	food	substance|substance[175]	giv|new[175]	_	_
15-26	3066-3072	matrix	substance[175]	new[175]	_	_
15-27	3073-3077	into	_	_	_	_
15-28	3078-3081	the	object[176]	giv[176]	_	_
15-29	3082-3098	gastrointestinal	object[176]	giv[176]	_	_
15-30	3099-3104	tract	object[176]	giv[176]	_	_
15-31	3105-3106	.	_	_	_	_

#Text=Several methodologies can be used to assess the bioaccessibility of contaminants or nutrients : 1 ) in vitro , 2 ) ex vivo , 3 ) in situ and 4 ) in vivo models .
16-1	3107-3114	Several	abstract[177]	new[177]	_	_
16-2	3115-3128	methodologies	abstract[177]	new[177]	_	_
16-3	3129-3132	can	_	_	_	_
16-4	3133-3135	be	_	_	_	_
16-5	3136-3140	used	_	_	_	_
16-6	3141-3143	to	_	_	_	_
16-7	3144-3150	assess	_	_	_	_
16-8	3151-3154	the	abstract[178]	giv[178]	_	_
16-9	3155-3171	bioaccessibility	abstract[178]	giv[178]	_	_
16-10	3172-3174	of	abstract[178]	giv[178]	_	_
16-11	3175-3187	contaminants	abstract[178]|substance	giv[178]|new	_	_
16-12	3188-3190	or	abstract[178]	giv[178]	_	_
16-13	3191-3200	nutrients	abstract[178]|substance	giv[178]|new	_	_
16-14	3201-3202	:	_	_	_	_
16-15	3203-3204	1	_	_	_	_
16-16	3205-3206	)	_	_	_	_
16-17	3207-3209	in	_	_	_	_
16-18	3210-3215	vitro	organization	new	coref	17-7[187_0]
16-19	3216-3217	,	_	_	_	_
16-20	3218-3219	2	_	_	_	_
16-21	3220-3221	)	_	_	_	_
16-22	3222-3224	ex	abstract[182]	new[182]	coref	16-33[0_182]
16-23	3225-3229	vivo	abstract[182]	new[182]	_	_
16-24	3230-3231	,	abstract[182]	new[182]	_	_
16-25	3232-3233	3	abstract[182]	new[182]	_	_
16-26	3234-3235	)	_	_	_	_
16-27	3236-3238	in	_	_	_	_
16-28	3239-3243	situ	abstract	new	_	_
16-29	3244-3247	and	_	_	_	_
16-30	3248-3249	4	_	_	_	_
16-31	3250-3251	)	_	_	_	_
16-32	3252-3254	in	_	_	_	_
16-33	3255-3259	vivo	abstract|abstract[185]	giv|new[185]	coref|coref	17-7[188_185]|17-16
16-34	3260-3266	models	abstract[185]	new[185]	_	_
16-35	3267-3268	.	_	_	_	_

#Text=Among the techniques mentioned before , in vitro models are more commonly used than in vivo models , because of their simplicity , lower cost , lack of ethical issues and good reproducibility under controlled conditions .
17-1	3269-3274	Among	_	_	_	_
17-2	3275-3278	the	abstract[186]	new[186]	_	_
17-3	3279-3289	techniques	abstract[186]	new[186]	_	_
17-4	3290-3299	mentioned	abstract[186]	new[186]	_	_
17-5	3300-3306	before	abstract[186]	new[186]	_	_
17-6	3307-3308	,	_	_	_	_
17-7	3309-3311	in	organization[187]|abstract[188]	giv[187]|giv[188]	coref	17-16[190_188]
17-8	3312-3317	vitro	organization[187]|abstract[188]	giv[187]|giv[188]	_	_
17-9	3318-3324	models	abstract[188]	giv[188]	_	_
17-10	3325-3328	are	_	_	_	_
17-11	3329-3333	more	_	_	_	_
17-12	3334-3342	commonly	_	_	_	_
17-13	3343-3347	used	_	_	_	_
17-14	3348-3352	than	_	_	_	_
17-15	3353-3355	in	_	_	_	_
17-16	3356-3360	vivo	abstract|abstract[190]	giv|giv[190]	ana	17-21[0_190]
17-17	3361-3367	models	abstract[190]	giv[190]	_	_
17-18	3368-3369	,	_	_	_	_
17-19	3370-3377	because	_	_	_	_
17-20	3378-3380	of	_	_	_	_
17-21	3381-3386	their	abstract|abstract[192]	giv|new[192]	_	_
17-22	3387-3397	simplicity	abstract[192]	new[192]	_	_
17-23	3398-3399	,	_	_	_	_
17-24	3400-3405	lower	abstract[193]	new[193]	_	_
17-25	3406-3410	cost	abstract[193]	new[193]	_	_
17-26	3411-3412	,	_	_	_	_
17-27	3413-3417	lack	abstract[194]	new[194]	_	_
17-28	3418-3420	of	abstract[194]	new[194]	_	_
17-29	3421-3428	ethical	abstract[194]|abstract[195]	new[194]|new[195]	_	_
17-30	3429-3435	issues	abstract[194]|abstract[195]	new[194]|new[195]	_	_
17-31	3436-3439	and	_	_	_	_
17-32	3440-3444	good	abstract[196]	new[196]	_	_
17-33	3445-3460	reproducibility	abstract[196]	new[196]	_	_
17-34	3461-3466	under	abstract[196]	new[196]	_	_
17-35	3467-3477	controlled	abstract[196]|abstract[197]	new[196]|giv[197]	_	_
17-36	3478-3488	conditions	abstract[196]|abstract[197]	new[196]|giv[197]	_	_
17-37	3489-3490	.	_	_	_	_

#Text=The present work evaluated some acrylamide mitigation strategies , employing a fractional factorial design experiment , and their influence on textural properties and bioaccesibility , by an in vitro simulated digestion assay .
18-1	3491-3494	The	abstract[198]	new[198]	_	_
18-2	3495-3502	present	abstract[198]	new[198]	_	_
18-3	3503-3507	work	abstract[198]	new[198]	_	_
18-4	3508-3517	evaluated	_	_	_	_
18-5	3518-3522	some	abstract[201]|abstract[202]	giv[201]|giv[202]	coref|ana	18-5[202_201]|18-18[0_202]
18-6	3523-3533	acrylamide	substance|abstract[200]|abstract[201]|abstract[202]	giv|giv[200]|giv[201]|giv[202]	_	_
18-7	3534-3544	mitigation	abstract[200]|abstract[201]|abstract[202]	giv[200]|giv[201]|giv[202]	_	_
18-8	3545-3555	strategies	abstract[201]|abstract[202]	giv[201]|giv[202]	_	_
18-9	3556-3557	,	abstract[202]	giv[202]	_	_
18-10	3558-3567	employing	abstract[202]	giv[202]	_	_
18-11	3568-3569	a	abstract[202]|event[205]	giv[202]|new[205]	_	_
18-12	3570-3580	fractional	abstract[202]|event[205]	giv[202]|new[205]	_	_
18-13	3581-3590	factorial	abstract[202]|abstract|event[205]	giv[202]|new|new[205]	_	_
18-14	3591-3597	design	abstract[202]|abstract|event[205]	giv[202]|new|new[205]	_	_
18-15	3598-3608	experiment	abstract[202]|event[205]	giv[202]|new[205]	_	_
18-16	3609-3610	,	abstract[202]	giv[202]	_	_
18-17	3611-3614	and	abstract[202]	giv[202]	_	_
18-18	3615-3620	their	abstract[202]|abstract|abstract[207]	giv[202]|giv|giv[207]	_	_
18-19	3621-3630	influence	abstract[202]|abstract[207]	giv[202]|giv[207]	_	_
18-20	3631-3633	on	abstract[202]|abstract[207]	giv[202]|giv[207]	_	_
18-21	3634-3642	textural	abstract[202]|abstract[207]|abstract[208]|abstract[209]	giv[202]|giv[207]|giv[208]|giv[209]	coref	18-21[209_208]
18-22	3643-3653	properties	abstract[202]|abstract[207]|abstract[208]|abstract[209]	giv[202]|giv[207]|giv[208]|giv[209]	_	_
18-23	3654-3657	and	abstract[202]|abstract[207]|abstract[209]	giv[202]|giv[207]|giv[209]	_	_
18-24	3658-3673	bioaccesibility	abstract[202]|abstract[207]|abstract[209]|abstract	giv[202]|giv[207]|giv[209]|new	_	_
18-25	3674-3675	,	_	_	_	_
18-26	3676-3678	by	_	_	_	_
18-27	3679-3681	an	abstract[212]	new[212]	_	_
18-28	3682-3684	in	abstract[212]	new[212]	_	_
18-29	3685-3690	vitro	abstract[212]	new[212]	_	_
18-30	3691-3700	simulated	abstract[212]	new[212]	_	_
18-31	3701-3710	digestion	abstract|abstract[212]	giv|new[212]	_	_
18-32	3711-3716	assay	abstract[212]	new[212]	_	_
18-33	3717-3718	.	_	_	_	_
